Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000721498 | SCV000852574 | uncertain significance | not provided | 2018-07-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001037069 | SCV001200466 | uncertain significance | RYR1-related disorder | 2023-10-15 | criteria provided, single submitter | clinical testing | This sequence change affects codon 1165 of the RYR1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the RYR1 protein. This variant is present in population databases (rs772616442, gnomAD 0.01%). This variant has been observed in individual(s) with RYR1-related disease (PMID: 30155738). ClinVar contains an entry for this variant (Variation ID: 590516). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002477666 | SCV002783295 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-09-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV003514402 | SCV004358057 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-02-24 | criteria provided, single submitter | clinical testing | This variant is located in the RYR1 protein. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with unspecified RYR1-related disorder (PMID: 30155738) and has not been reported in individuals with malignant hyperthermia susceptibility in the literature. This variant has been identified in 16/282864 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
All of Us Research Program, |
RCV003514402 | SCV004820812 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-09-04 | criteria provided, single submitter | clinical testing | This variant is located in the RYR1 protein. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with unspecified RYR1-related disorder (PMID: 30155738) and has not been reported in individuals with malignant hyperthermia susceptibility in the literature. This variant has been identified in 16/282864 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |